Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial

Autor: Charlotte C. van Ruiten, Dick J. Veltman, Madelief Wijdeveld, Jennifer S ten Kulve, Mark H. H. Kramer, Max Nieuwdorp, Richard G. IJzerman

Publikováno v: Diabetes, obesity & metabolism, 24(8), 1588-1597. Wiley-Blackwell
van Ruiten, C C, Veltman, D J, Wijdeveld, M, ten Kulve, J S, Kramer, M H H, Nieuwdorp, M & IJzerman, R G 2022, ' Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes : A randomized controlled trial ', Diabetes, Obesity and Metabolism, vol. 24, no. 8, pp. 1588-1597 . https://doi.org/10.1111/dom.14732
Diabetes, Obesity and Metabolism, 24(8), 1588-1597. Wiley-Blackwell

Aims: Sodium-glucose cotransporter-2 inhibitors induce less weight loss than expected. This may be explained by sodium-glucose cotransporter-2 inhibitor-induced alterations in central reward- and satiety circuits, leading to increased appetite and fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11a5b569112c67cfba8ab7d4b6cf9379
https://pure.amc.nl/en/publications/combination-therapy-with-exenatide-decreases-the-dapagliflozininduced-changes-in-brain-responses-to-anticipation-and-consumption-of-palatable-food-in-patients-with-type-2-diabetes(2ad8cf39-42c8-4159-b8b8-1c31d5e1338a).html

GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trials

Autor: Richard G. IJzerman, Jennifer S. ten Kulve, Liselotte van Bloemendaal, Mark M. Smits, Daniël H. van Raalte, Lennart Tonneijck, Marcel H.A. Muskiet, Mark H.H. Kramer

Publikováno v: Nutrition (Burbank, Los Angeles County, Calif.), 67-68:110524. Elsevier Inc.
Smits, M M, ten Kulve, J S, van Bloemendaal, L, Tonneijck, L, Muskiet, M H A, Kramer, M H H, Ijzerman, R G & van Raalte, D H 2019, ' GLP-1 receptor agonists do not affect sodium intake : Exploratory analyses from two randomized clinical trials ', Nutrition, vol. 67-68, 110524 . https://doi.org/10.1016/j.nut.2019.06.005
Nutrition, 67-68:110524. Elsevier Inc.

Objectives Excessive sodium intake, despite current dietary advice, remains a global issue with cardiovascular and renal consequences. The aim of this study was to determine whether glucagon-like peptide receptor agonists (GLP-1 RAs), used as antihyp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d222c49420de63e597a6c9a2da3dae5
https://pure.amc.nl/en/publications/glp1-receptor-agonists-do-not-affect-sodium-intake-exploratory-analyses-from-two-randomized-clinical-trials(7e99f762-f91c-483f-8631-65da8b1b5ced).html

Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes

Autor: Dick J. Veltman, Jennifer S. ten Kulve, Madeleine L. Drent, Frederik Barkhof, Richard G. IJzerman, Liselotte van Bloemendaal, Michaela Diamant

Publikováno v: Ten Kulve, J S, Veltman, D J, van Bloemendaal, L, Barkhof, F, Drent, M L, Diamant, M & IJzerman, R G 2016, ' Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes ', Diabetes Care, vol. 39, no. 2, pp. 214-21 . https://doi.org/10.2337/dc15-0772
Diabetes Care, 39(2), 214-21. American Diabetes Association Inc.
Diabetes Care, 39(2), 214-221. American Diabetes Association Inc.
ten Kulve, J S, Veltman, D J, van Bloemendaal, L, Barkhof, F, Drent, M L, Diamant, M & IJzerman, R G 2016, ' Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes ', Diabetes Care, vol. 39, no. 2, pp. 214-221 . https://doi.org/10.2337/dc15-0772

OBJECTIVE Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are associated with reduced appetite and body weight. We investigated whether these effects could be mediated by the central nervous system (CNS). RESEARCH DESIGN AND METHODS We performed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35801855e630f4d811840a5d3274fa6
https://doi.org/10.2337/dc15-0772

Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin

Autor: Frederik Barkhof, Jennifer S. ten Kulve, Jesus Landeira-Fernandez, Liselotte van Bloemendaal, Eelco van Duinkerken, Richard G. IJzerman, Dick J. Veltman, Michaela Diamant, Gabriel Bernardes

Publikováno v: METABOLIC BRAIN DISEASE, 33(4), 1211-1222. Springer New York
Metabolic Brain Disease
Bernardes, G, IJzerman, R G, Ten Kulve, J S, Barkhof, F, Diamant, M, Veltman, D J, Landeira-Fernandez, J, van Bloemendaal, L & van Duinkerken, E 2018, ' Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients : relationship with adiposity, glucose, and insulin ', METABOLIC BRAIN DISEASE, vol. 33, no. 4, pp. 1211-1222 . https://doi.org/10.1007/s11011-018-0223-5

Type 2 diabetes (T2DM) is associated with structural cortical and subcortical alterations, although it is insufficiently clear if these alterations are driven by obesity or by diabetes and its associated complications. We used FreeSurfer5.3 and FSL-F

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17169db97da7eeefc19a1d6d428c5fb3
https://research.vumc.nl/en/publications/e3717867-d738-4738-8353-da61490ca3cc

14. Liraglutide Decreases Food Related CNS Activation after Short-Term, but Not after Longer-Term Treatment in Patients with Diabetes (159-OR)

Autor: Richard G. IJzerman, Madeleine L. Drent, Frederik Barkhof, Dick J. Veltman, M. Diamant, Jennifer S. ten Kulve, Liselotte van Bloemendaal

Publikováno v: Nederlands Tijdschrift voor Diabetologie. 13:66-71

The central nervous system (CNS) is a major player in the regulation of feeding. Gut-derived hormones, such as glucagon- like peptide-1 (GLP-1), may relay information about the nutritional status to the CNS. Treatment with GLP-1 agonists, such as lir

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd1ff71de42e544e491bfe1deffb48f2
https://doi.org/10.1007/s12467-015-0035-8